Post by olukumi on Apr 30, 2016 11:26:32 GMT
More reason to be skeptical of GMOs and support any legislation that requires labeling.
Genetically engineered bovine growth hormone (rbGH) which is banned in 27 countries including Canada, Australia, New Zealand, Japan, Israel and European Union linked to cancer.
- Unlabeled milk from cows treated with biosynthetic growth hormones: a case of regulatory abdication.
Levels of insulin-like growth factor-1 (IGF-1) are substantially elevated and more bioactive in the milk of cows hyperstimulated with the biosynthetic bovine growth hormones rBGH, and are further increased by pasteurization. IGF-1 is absorbed from the gastrointestinal tract, as evidenced by marked growth-promoting effects even in short-term tests in mature rats, and absorption is likely to be still higher in infants. Converging lines of evidence incriminate IGF-1 in rBGH milk as a potential risk factor for both breast and gastrointestinal cancers.
www.ncbi.nlm.nih.gov/pubmed/8932606
- Inconclusive evidence on himans but strong inference from American Cancer Society suggesting other harm to humans
Summary
The available evidence shows that the use of rBGH can cause adverse health effects in cows. The evidence for potential harm to humans is inconclusive. It is not clear that drinking milk produced using rBGH significantly increases IGF-1 levels in humans or adds to the risk of developing cancer. More research is needed to help better address these concerns.
The increased use of antibiotics to treat rBGH-induced mastitis does promote the development of antibiotic-resistant bacteria, but the extent to which these are transmitted to humans is unclear.
The American Cancer Society (ACS) has no formal position regarding rBGH.
m.cancer.org/cancer/cancercauses/othercarcinogens/athome/recombinant-bovine-growth-hormone
Breast cancer fund
CATEGORY*: Endocrine disruptor
FOUND IN: Dairy products
THE GIST: This hormone is injected into dairy cows to increase milk production and is found in milk, ice cream, buttermilk, cheese, yogurt and other dairy products. Though research outcomes are mixed, several human studies have linked dairy consumption with increased risk for breast cancer.
State of the Evidence on rBGH and rBST
Despite opposition from physicians, scientists and consumer advocacy groups, the U.S. Food and Drug Administration in 1993 approved Monsanto's genetically engineered hormone product, recombinant bovine growth hormone (rBGH), for injection in dairy cows to increase milk production (Eaton, 2004). This hormone quickly found its way (without labeling) into the U.S. milk supply and from there into ice cream, buttermilk, cheese, yogurt and other dairy products. Since its introduction, rBGH (subsequently renamed recombinant bovine somatotrophin, rBST) has proven controversial because of its potentially carcinogenic effects.
www.breastcancerfund.org/clear-science/radiation-chemicals-and-breast-cancer/bovine-growth-hormone.html?referrer=https://www.google.com/
Genetically engineered bovine growth hormone (rbGH) which is banned in 27 countries including Canada, Australia, New Zealand, Japan, Israel and European Union linked to cancer.
- Unlabeled milk from cows treated with biosynthetic growth hormones: a case of regulatory abdication.
Levels of insulin-like growth factor-1 (IGF-1) are substantially elevated and more bioactive in the milk of cows hyperstimulated with the biosynthetic bovine growth hormones rBGH, and are further increased by pasteurization. IGF-1 is absorbed from the gastrointestinal tract, as evidenced by marked growth-promoting effects even in short-term tests in mature rats, and absorption is likely to be still higher in infants. Converging lines of evidence incriminate IGF-1 in rBGH milk as a potential risk factor for both breast and gastrointestinal cancers.
www.ncbi.nlm.nih.gov/pubmed/8932606
- Inconclusive evidence on himans but strong inference from American Cancer Society suggesting other harm to humans
Summary
The available evidence shows that the use of rBGH can cause adverse health effects in cows. The evidence for potential harm to humans is inconclusive. It is not clear that drinking milk produced using rBGH significantly increases IGF-1 levels in humans or adds to the risk of developing cancer. More research is needed to help better address these concerns.
The increased use of antibiotics to treat rBGH-induced mastitis does promote the development of antibiotic-resistant bacteria, but the extent to which these are transmitted to humans is unclear.
The American Cancer Society (ACS) has no formal position regarding rBGH.
m.cancer.org/cancer/cancercauses/othercarcinogens/athome/recombinant-bovine-growth-hormone
Breast cancer fund
CATEGORY*: Endocrine disruptor
FOUND IN: Dairy products
THE GIST: This hormone is injected into dairy cows to increase milk production and is found in milk, ice cream, buttermilk, cheese, yogurt and other dairy products. Though research outcomes are mixed, several human studies have linked dairy consumption with increased risk for breast cancer.
State of the Evidence on rBGH and rBST
Despite opposition from physicians, scientists and consumer advocacy groups, the U.S. Food and Drug Administration in 1993 approved Monsanto's genetically engineered hormone product, recombinant bovine growth hormone (rBGH), for injection in dairy cows to increase milk production (Eaton, 2004). This hormone quickly found its way (without labeling) into the U.S. milk supply and from there into ice cream, buttermilk, cheese, yogurt and other dairy products. Since its introduction, rBGH (subsequently renamed recombinant bovine somatotrophin, rBST) has proven controversial because of its potentially carcinogenic effects.
www.breastcancerfund.org/clear-science/radiation-chemicals-and-breast-cancer/bovine-growth-hormone.html?referrer=https://www.google.com/